DG: Anti-malaria drug may have reduced Covid-19 patients’ need for ICU

Annabelle Lee

Modified 7 Apr 2020, 2:45 pm

UPDATED 10.40PM | CORONAVIRUS | Malaysia’s use of an antimalarial drug appears to have prevented Covid-19 from worsening and thus contributed to fewer patients in the ICU.

Health Ministry director-general Dr Noor Hisham Abdullah said today that hospitals have been administering hydroxychloroquine on an off-label basis since the outbreak began...

Share this story


By posting a comment, you agree to our Terms & Conditions as stipulated in full here


Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.


Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.